Findings from Hospital Clinico Universidad de Chile in Acute Kidney Injury Reported (A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development...).

Předmět:
Zdroj: Drug Week; 10/27/2023, p175-175, 1p
Abstrakt: Keywords: Acute Kidney Injury; Biological Factors; Biomarkers; Blood Diseases and Conditions; Bloodstream Infection; Chronic Kidney Disease; Colony Stimulating Factors; Connective Tissue Cells; Critical Care; Critical Care Medicine; Cytokines; Diagnostics and Screening; Erythropoietin; Fibroblasts; Health and Medicine; Intercellular Signaling Peptides and Proteins; Kidney Diseases and Conditions; Peptides; Proteins; Risk and Prevention; Sepsis; Septicemia; Therapy EN Acute Kidney Injury Biological Factors Biomarkers Blood Diseases and Conditions Bloodstream Infection Chronic Kidney Disease Colony Stimulating Factors Connective Tissue Cells Critical Care Critical Care Medicine Cytokines Diagnostics and Screening Erythropoietin Fibroblasts Health and Medicine Intercellular Signaling Peptides and Proteins Kidney Diseases and Conditions Peptides Proteins Risk and Prevention Sepsis Septicemia Therapy 175 175 1 10/24/23 20231027 NES 231027 2023 OCT 26 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in acute kidney injury. For more information on this research see: A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort. [Extracted from the article]
Databáze: Complementary Index